Suppliers / Seacross Pharma (Europe)

Seacross Pharma (Europe)

United Kingdom 30 employees Updated 9 July 2026

Seacross Pharma (Europe) is an API and finished-dose manufacturer based in United Kingdom. It holds 3 active US drug master files across a filed portfolio of 3 molecules. Its filings concentrate with EMA, FAMHP (BE) and MHRA (UK). Its GMP standing is certified by MHRA (UK) and EMA.

3
active US DMFs
0
valid CEPs
5
registered plants
377
filings across 14 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
London, United Arab Emirates Not on file
Stanmore HA7 1BT, United Arab Emirates Not on file
LONDON, United Kingdom Not on file
Blackrock, Ireland Not on file
Vialonga, Portugal Not on file

What they file, and where

Molecule Regulators Docs
Bortezomib US FDA 1
Leucovorin Calcium US FDA 1
Thiotepa US FDA 1

Also appears on these molecule pages

Azacitidine finished dose Bendamustine finished dose Bortezomib API Cisatracurium finished dose Decitabine finished dose Leucovorin API Paclitaxel finished dose Pemetrexed Disodium finished dose Plerixafor finished dose Sodium Valproate finished dose Teicoplanin finished dose Thiotepa API

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 111 1
FAMHP (BE) 104 None
MHRA (UK) 90 2
AIFA (IT) 16 None
INFARMED (PT) 14 None
EDE (AE) 13 None

Questions about Seacross Pharma (Europe)

Does Seacross Pharma (Europe) hold a US DMF or a CEP?
Seacross Pharma (Europe) holds 3 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Seacross Pharma (Europe) manufacture?
5 registered sites are on record, in United Arab Emirates, United Kingdom, Ireland and Portugal (London, Stanmore Ha7 1bt and London among others). Every site is listed on this page with the register it came from.
What does Seacross Pharma (Europe) make?
3 molecules are on record against Seacross Pharma (Europe), including Bortezomib, Leucovorin Calcium and Thiotepa. Each links through to that molecule's full manufacturer list.
Which regulators recognise Seacross Pharma (Europe)'s GMP?
Current GMP certificates are on record from MHRA (UK) and EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Seacross Pharma (Europe) comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

MSN Laboratories shares 2 molecules Natco Pharma shares 2 molecules Hetero shares 1 molecule Dr Reddy's Laboratories shares 1 molecule Biophore India Pharmaceuticals shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates